ELPIS BIOPHARMACEUTICALS

elpis-biopharmaceuticals-logo

Elpis Biopharmaceuticals provides platforms that make it possible to create biologic and cellular treatments with several functionalities to boost the antitumor immune response and get around resistance mechanisms that are specific to each tumour microenvironment.

#SimilarOrganizations #People #Website #More

ELPIS BIOPHARMACEUTICALS

Social Links:

Industry:
Biotechnology

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.elpisbiopharmaceuticals.com

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins


Similar Organizations

avid-radiopharmaceuticals-logo

Avid Radiopharmaceuticals

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

tavec-pharma-logo

Tavec pharma

Tavec Pharmaceuticals is developing injectable therapies to treat cancers.

Current Employees Featured

yan-chen_image

Yan Chen
Yan Chen Founder and CEO @ Elpis Biopharmaceuticals
Founder and CEO
2017-07-01

Founder


yan-chen_image

Yan Chen

Official Site Inspections

http://www.elpisbiopharmaceuticals.com

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Elpis Biopharmaceuticals"

Elpis Biopharmaceuticals - Crunchbase Company Profile & Funding

Elpis Biopharmaceuticals provides platforms that make it possible to create biologic and cellular treatments with several functionalities to boost the antitumor immune response and get around …See details»

Elpis Biopharmaceuticals Company Profile | Management and

Www.elpisbiopharmaceuticals.com Elpis Biopharmaceuticals Profile and History Elpis Biopharmaceuticals is engineering and developing multifunctional immunotherapies, which …See details»

Elpis Biopharmaceuticals - Org Chart, Teams, Culture & Jobs - The …

View Elpis Biopharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Elpis Biopharmaceuticals - Company Profile & Staff Directory

Elpis biopharmaceuticals is committed to developing next generation cellular and biologic therapeutics for the treatment of cancer patientsSee details»

Elpis Biopharmaceuticals - Craft

Elpis Biopharmaceuticals is a company developing biological and cellular therapeutics for difficult-to-treat cancers. It offers mADs platform to discover fully human therapeutic antibodies and …See details»

Elpis Biopharmaceuticals - LinkedIn

Elpis biopharmaceuticals is committed to developing next generation cellular and biologic therapeutics for the treatment of cancer patientsSee details»

Elpis BioPharmaceuticals - Company Profile - Tracxn

Sep 11, 2024 Elpis BioPharmaceuticals - Developer of therapeutics targeting the immune response for treating tumors. Raised a total funding of $40M over 1 round. Founded by Yan …See details»

About Us - Elpis Biopharmaceuticals

Immuno-modulator. Activation of certain immune cells, such as NK cells and cytotoxic T-Cells, can effectively eradicate tumor lesions. However, immunosuppressive cells including …See details»

Elpis Biopharmaceuticals CEO and Key Executive Team - Craft

Elpis Biopharmaceuticals's President and CEO is Yan Chen. Other executives include Kehao Zhao, Chief Scientific Officer; Charles Zhao, Vice President of Clinical Development. See the …See details»

Elpis Biopharmaceuticals - Overview, News & Similar ... - ZoomInfo

Jan 12, 2022 Popular Searches Elpis BioPharmaceuticals Elpis Biopharmaceuticals Corp Elpis Inc Biopharmaceuticals Corp Elpisbiopharmaceuticals SIC Code 87,873 NAICS Code 54,541 …See details»

Elpis Biopharmaceuticals | Insights

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Elpis Biopharmaceuticals - VentureRadar

Similar Companies: Asymmetrex USA n/a Asymmetrex, LLC is a for-profit limited liability company with a mission of advancing innovative adult tissue stem cell technologies to applications in …See details»

Corporate Overview - Elpis Biopharmaceuticals

Immuno-modulator. Activation of certain immune cells, such as NK cells and cytotoxic T-Cells, can effectively eradicate tumor lesions. However, immunosuppressive cells including …See details»

ELPIS BIOPHARMACEUTICALS, CORP. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ELPIS BIOPHARMACEUTICALS, CORP. of Lexington, MA. Get the latest business insights from …See details»

Elpis Biopharmaceuticals - Products, Competitors, Financials, …

Elpis Biopharmaceuticals develops multifunctional immunotherapies, including dual-targeted armored CAR-T cells and bispecific biologics, aimed at activating the immune system to …See details»

Elpis Biopharmaceuticals Debuts with Series A Funding and …

Oct 29, 2020 Company raises $30 Million to allocate to pre-clinical pipeline development. LEXINGTON, MA – October 29, 2020 — Elpis Biopharmaceuticals today announced the …See details»

Elpis Biopharmaceuticals Strengthens Scientific Advisory Board

LEXINGTON, MA – May 18, 2021 — Elpis Biopharmaceuticals, a biopharmaceutical company developing next generation multifunctional immunotherapies to transform cancer treatment, …See details»

Elpis Biopharmaceuticals Showcases Preclinical Data from its ...

Apr 8, 2022 LEXINGTON, Mass.--(BUSINESS WIRE)--Elpis Biopharmaceuticals, an IND stage biopharmaceutical company developing next generation immunotherapies to transform cancer …See details»

Elpis Appoints Leading Immuno-Oncology Expert Dr. Vincenzo …

About Elpis Biopharmaceuticals Elpis Biopharmaceuticals is engineering and developing multifunctional immunotherapies, that modulate disease biology with great precision and …See details»

linkstock.net © 2022. All rights reserved